Impact of HFNC application on mortality and intensive care length of stay in acute respiratory failure secondary to COVID-19 pneumonia.
Heart Lung
; 50(3): 425-429, 2021.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1077912
ABSTRACT
BACKGROUND:
In Covid-19 pneumonia, high mortality rates reported in intubated patients have raised non-invasive methods of respiratory support.OBJECTIVE:
We aimed to evaluate the impact of HFNC application on intubation requirement, intensive care length of stay, and short-term mortality in patients with COVID-19 pneumonia. MATERIAL-METHOD:
Patients receiving oxygen by reservoir mask or HFNC therapy in our intensive care units due to COVID-19 pneumonia were included in the study. Group H consisted of patients who received HFNC, and Group K consisted of patients who received conventional oxygen therapy (COT). The number of patients intubated, duration of intensive care stay and short-term mortality were recorded.RESULTS:
43 patients were included. The short-term mortality and the number of patients with intubation need was lower in Group H. There was no significant difference between the Groups in the length of intensive care stay.CONCLUSION:
Administration of HFNC in respiratory failure secondary to COVID-19 pneumonia decreases the need for intubation and mortality.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Insuficiencia Respiratoria
/
COVID-19
Tipo de estudio:
Estudio experimental
/
Ensayo controlado aleatorizado
Límite:
Humanos
Idioma:
Inglés
Revista:
Heart Lung
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
J.hrtlng.2021.02.009
Similares
MEDLINE
...
LILACS
LIS